The Oncolytic Virus Therapy Market report further sheds light on the emerging growth opportunities, challenges, market threats, limitations, and factors likely to restrict the growth of the Oncolytic Virus Therapy market. It provides a comprehensive evaluation of the global Oncolytic Virus Therapy market from various perspectives to deliver a detailed, informative, and precise analysis of regional growth, competition, and market segmentation, among other factors. Moreover, it also gives an accurate account of the significant breakthroughs and developments that influence the global Oncolytic Virus Therapy market. It also focuses on both the global as well as the regional expansion of the Oncolytic Virus Therapy industry to give an overall analysis.
The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. Cancer is a major cause of deaths in countries across the globe and it is estimated that in 2020, over 1.8 million new cancer cases were diagnosed in the US, with over 0.6 Million deaths occurring due to the disease. Also, around 70% of cancer mortality occurs in low and middle-income countries. Oncolytic virus therapy (a type of immunotherapy) uses engineered viruses to destroy cancer cells without affecting healthy cells in the human body. Once a cancer cell is destroyed, it releases cancer antigens that trigger immune responses to destroy other tumor cells in the body.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/541
The study offers comprehensive coverage of the qualitative and quantitative analysis of the Oncolytic Virus Therapy market along with crucial statistical data about the Oncolytic Virus Therapy market. The research study provides historical data and offers accurate forecast estimation until 2030. The report also profiles established and emerging players of the market, covering the business overview, product portfolio, strategic alliances, and business expansion strategies.
Key players in the market include Oncolytics Biotech Inc., Lokon Pharma AB, PsiOxus Therapeutics, Sorrento Therapeutics Inc., CG Oncology Inc., ORYX GmbH Co. KG, VCNBiosciences, DNAtrix, Targovax, and SillaJen Inc.
Highlights from the Report
- In October 2020, Oncolytics Biotech made announced the signing of a partnership agreement with AIO and Roche to commence a Phase ½ trial(GOBLET) for gastrointestinal cancer. The trial would examine the use of pelareorep with anti-PD-L1 checkpoint inhibitor by Roche in cancer patients.
- Monoclonal antibodies are considered beneficial in stimulating immune responses to destroy cancer cells. In addition, certain monoclonal antibodies are capable of blocking the connection between the cellular growth promoting proteins and cancer cells, thereby killing the cancer cells.
- Oncolytic virus therapy in the treatment of lung cancer is used to deliver specific immunomodulatory or therapeutic genes to destroy cancer cells. Oncolytic virus therapy holds significant potential to improve tumor cell oncolysis and circumvent resistance mechanisms of tumor cells. It was estimated that in 2020, over 0.2 million adults in the US were diagnosed with lung cancer, which accounted for around 13.0% of the total individuals diagnosed with cancer in the same year.
Request a discount on the report @ https://www.emergenresearch.com/request-discount/541
The report is an investigative study of the technological developments and product advancements, along with a regional analysis for each product and application offered in the market. The fundamental objective of the report is to give an insight into the workings of the Oncolytic Virus Therapy industry. It provides an accurate and strategic outlook of the market with a thorough assessment of the segments and sub-segments of the market. It provides a panoramic view of the industry to offer a deeper understanding of the global industry.
Emergen Research has segmented the global oncolytic virus therapy market on the basis of type, application, end-use, and region:
Type Outlook (Revenue, USD Million; 2021–2028)
- Monoclonal Antibodies
- Checkpoint Inhibitors
- Cancer Vaccines
- Immunomodulators
Application Outlook (Revenue, USD Million; 2021–2028)
- Melanoma
- Lung Cancer
- Breast Cancer
- Others
End-Use Outlook (Revenue, USD Million; 2021–2028)
- Hospitals
- Clinics
- Research Institutes
- Others
The complete regional analysis covers:
North America (U.S., Canada, Mexico
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
The report offers a comprehensive understanding of the impact of the COVID-19 pandemic on the overall market growth and expansion. COVID-19 has affected the global economy by interfering with production and demand, causing market disruption, and inducing financial instability.
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/541
Key Points of Oncolytic Virus Therapy Market:
Extensive coverage of the analysis of the Oncolytic Virus Therapy market
Key insights into the regional spread of the industry in key geographies
Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market
Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Oncolytic Virus Therapy market
Complete data about the key manufacturers and vendors in the Oncolytic Virus Therapy market
Thank you for reading our report. Customization of the report is available. To know more, please connect with us, and our team will ensure the report is customized as per your requirements.
Take a Look at our Related Reports:
printed circuit board (pcb) design software market
https://www.emergenresearch.com/industry-report/printed-circuit-board-design-software-market
wireless brain sensor market
https://www.emergenresearch.com/industry-report/wireless-brain-sensor-market
wireless electronic health records market
https://www.emergenresearch.com/industry-report/wireless-electronic-health-records-market
optically clear adhesive market
https://www.emergenresearch.com/industry-report/optically-clear-adhesive-market
maritime autonomous surface ships market
https://www.emergenresearch.com/industry-report/maritime-autonomous-surface-ships-market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
